It’s been over a year since nursing homes began implementing – and enduring pain points – in the transition from Section G to ...
First for Women on MSN1d
MDs Share 5 Things To Know About Blood Sugar Monitors—Even if You Don't Have DiabetesThe latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...
A research study co-authored by Florida Cancer Specialists & Research Institute (FCS) physicians and senior leaders will be ...
VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second ...
Media Disease Surveillance' (MDS) is an AI-driven tool that has been supporting event-based surveillance for infectious ...
Q4 2024 Earnings Call Transcript March 17, 2025 FibroGen, Inc. reports earnings inline with expectations. Reported EPS is $-0 ...
The MoHFW’s AI push spans multiple domains of public health, from infectious disease surveillance to telemedicine, ...
The Kerala government's ambitious semi-high-speed rail project, SilverLine, will not materialise as the Centre is ...
A new study that looked at possible improvements in post-acute care quality and outcomes following the 2014 Improving ...
H.C. Wainwright lowered the firm’s price target on Vor Bio (VOR) to $13 from $17.50 and keeps a Buy rating on the shares after the company ...
Thane Wettig; Interim Chief Executive Officer, Chief Commercial Officer; FibroGen Inc. David Delucia; Vice Presi ...
VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second half of 2025 Anticipate initiation of the first trem-cel+VCAR33 Treatment Sys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback